NL-OMON55996招募中不适用
AtheroGenic LipoprothEinS in Ischemic Stroke: The AGELESS Study - AGELESS
niversitätsspital Basel0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age > 18 years
- •- Atherosclerotic carotid stenosis NASCET 30 - 99%
- •- Ability to undergo a neck MR for carotid plaque imaging
- •- Ability to undergo a follow-up of at least 1 year
- •- For the prospective, longitudinal part: hemispheric ischemic stroke or
- •retinal ischemia ipsilateral to the carotid stenosis, with symptom onset within
- •- Written informed consent
排除标准
- •- Carotid stenosis due to causes other than atherosclerosis (e.g. carotid
- •dissection)
- •- Contraindication to MRI
- •- Lack of informed consent by patient or legal representative
研究者
相似试验
招募中
不适用
Atherogenic Lipoproteins in Ischemic StrokeIschemic StrokeNCT05090878University Hospital, Basel, Switzerland500
进行中（未招募）
不适用
Atherosclerosis and Acute Ischemic Stroke StudyInflammationIschemic StrokeAtherosclerosisNCT03685006Oslo University Hospital500
已完成
不适用
Thrombolysis Register of Acute Ischaemic Stroke in ChinaISRCTN69801104Beijing Tiantan Hospital (China)330
已完成
不适用
euroactive Steroids in Acute Ischemic Stroke: association with Cognitive, Functional and Neurological OutcomesAcute ischemic Stroke,neurologic status,cognitive assessment,functional status.Neuroactive steroidsAcute Ischemic StrokeElderly patientsCognitive impairmentFunctional impairment.TCTR20160510004Hospital Militar Central Cir My ¨Dr. Cosme Argerich¨.30
终止
4 期
INFLAMMATION and VASCULAR FUNCTION in ACUTE STROKE and TIA: TREATMENT WITH ATORVASTATIN and IRBESARTAAcute Ischaemic StrokeTransient Ischaemic AttackStroke - IschaemicACTRN12605000175673niversity of Western Australia40